Clinical trial
Extended Follow-Up of Young Women in Costa Rica Who Received Vaccination Against Human Papillomavirus Types 16 and 18 and Unvaccinated Controls
NCT00867464 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Extended Follow-Up of Young Women in Costa Rica Who Received Vaccination Against Human Papillomavirus Types 16 and 18 and Unvaccinated Controls
- Lead sponsor
- National Cancer Institute (NCI)
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- March 30, 2009
- Completion date
- December 23, 2026
- Enrollment
- 8,670 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anal carcinoma, cervical carcinoma, human papillomavirus infection, human papillomavirus-related cervical carcinoma, oral cavity carcinoma